Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ETANERCEPT Cause Peripheral arterial occlusive disease? 46 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Peripheral arterial occlusive disease have been filed in association with ETANERCEPT (ENBREL). This represents 0.0% of all adverse event reports for ETANERCEPT.

46
Reports of Peripheral arterial occlusive disease with ETANERCEPT
0.0%
of all ETANERCEPT reports
3
Deaths
40
Hospitalizations

How Dangerous Is Peripheral arterial occlusive disease From ETANERCEPT?

Of the 46 reports, 3 (6.5%) resulted in death, 40 (87.0%) required hospitalization, and 1 (2.2%) were considered life-threatening.

Is Peripheral arterial occlusive disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ETANERCEPT. However, 46 reports have been filed with the FAERS database.

What Other Side Effects Does ETANERCEPT Cause?

Drug ineffective (60,367) Rheumatoid arthritis (33,166) Pain (31,961) Arthralgia (27,429) Injection site pain (24,717) Off label use (20,178) Fatigue (19,907) Joint swelling (18,462) Injection site erythema (17,736) Condition aggravated (15,897)

What Other Drugs Cause Peripheral arterial occlusive disease?

NILOTINIB (319) METHOTREXATE (120) ADALIMUMAB (116) RIVAROXABAN (101) PONATINIB (90) IMATINIB (86) ASPIRIN (77) ATORVASTATIN (70) METOPROLOL (70) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (63)

Which ETANERCEPT Alternatives Have Lower Peripheral arterial occlusive disease Risk?

ETANERCEPT vs ETANERCEPT-SZZS ETANERCEPT vs ETELCALCETIDE ETANERCEPT vs ETEPLIRSEN ETANERCEPT vs ETESEVIMAB ETANERCEPT vs ETHACRYNIC ACID

Related Pages

ETANERCEPT Full Profile All Peripheral arterial occlusive disease Reports All Drugs Causing Peripheral arterial occlusive disease ETANERCEPT Demographics